Kerecis is a biotechnology company that develops and produces fish-skin-based products for tissue regeneration and wound care. The company's products are used in the treatment of chronic wounds, burns, and other tissue damage. Kerecis' patented technology uses fish skin, which is rich in Omega3 fatty acids, to create a biocompatible and fully functional material that can be used to regenerate human tissue. The company was founded in 2009 and is headquartered in Reykjavik, Iceland.